Research Education Component
Research Education Component
批准号:
10263716
负责人:
Xiongwei Zhu
金额:
$23.21万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-06-30
关键词:
AddressAgeAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaBasic ScienceClinicalClinical ResearchClinical SciencesCollaborationsCommunitiesCompetenceDementiaDevelopmentDiagnosisDirect CostsDiseaseEducational ActivitiesEducational process of instructingEquilibriumExtramural ActivitiesFacultyFamilyFosteringFundingFuture GenerationsGoalsGrantGrowthHealth Care CostsHealth ServicesHuman ResourcesIncidenceInfrastructureInstitutionInternationalKnowledgeLaboratory ResearchLeadMentorsMentorshipNatureNerve DegenerationParticipantPatientsPopulationPostdoctoral FellowResearchResearch PersonnelResearch Project GrantsResearch Project SummariesResearch SupportResearch TrainingResource SharingResourcesScienceScientistServicesSocietiesSpecialistTalentsTrainingTraining ProgramsTraining SupportTraining and InfrastructureTranslatingTranslational ResearchWorkaging populationcareercareer developmentclinical careclinical centercollaborative environmentcostdesigneducation researcheducation resourcesexperiencefaculty mentorfaculty researchhealthy aginginnovationinterdisciplinary collaborationneurobehavioralnovelprogramsresearch and developmentservice interventionsuccesstranslational research program
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The Research Education Component (REC) is aimed at fulfilling two critical needs in the Alzheimer's disease
(AD) and Alzheimer's disease related dementias (ADRD) community: 1) the number of current researchers and
clinical specialists in AD/ADRD are clearly inadequate to meet the needs of the rapid increase in the AD
population in the US and around world and 2) while we have made advances in bridging the knowledge gaps
in understanding neurodegenerative mechanisms through many years of research, advances in clinical care
are still lacking. As such, new scientists trained in the breadth of approaches with deep clinical
appreciation are required to promote progress in translational research in the AD/ADRD field and to
develop innovative and effective strategies for the diagnosis and the treatment. The REC program has
been specifically designed for selected Program Participants to provide rigorous scientific research training in
the AD/ADRD field along with extensive clinical exposure.
The REC specifically aims to train talented and promising junior faculty and research associates and
supports their career growth with individualized Research Plan and Mentoring Plan with clearly articulated
goals. The REC emphasizes rigorous scientific training in fundamental aspects of neurodegeneration and
mechanisms of diseases involving AD/ADRD and clinical perspectives through classroom teaching, AD/ADRD-
related laboratory research and mentored neurodegenerative clinical experiences combined with educational
forums that address important topics in clinical and translational AD/ADRD research and career growth.
The REC has identified a group of diverse promising candidates who will be encouraged to develop
new competencies under the mentorship of a faculty Mentoring committee composed of outstanding
Program Faculty including both clinical and basic researchers. The REC will also utilize the vast
educational and training resources available through CADRC-associated institutions including formal
programs, training grants, and other educational resources to enable the identified participants to advance
their research careers. This REC program will not only provide the necessary infrastructure for the training
of new AD/ADRD-related clinical/basic researchers, but also stimulate interdepartmental/interdisciplinary
collaborations among CADRC clinical and basic science researchers to serve the overall goal to accelerate
collaborative health services, interventional science, and translational neurobehavioral science research
specifically in AD/ADRD, augmenting activities of both the CADRC and national and international efforts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Mettl3-dependent RNA m6A dysregulation in Alzheimer's disease
-
批准号:10739065
-
项目类别:
-
资助金额:$215.63万
-
财政年份:2023
-
负责人:Xiongwei Zhu
-
依托单位:
Research Education Component
-
批准号:10474608
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2021
-
负责人:Xiongwei Zhu
-
依托单位:
Research Education Component
-
批准号:10675675
-
项目类别:
-
资助金额:$39.86万
-
财政年份:2021
-
负责人:Xiongwei Zhu
-
依托单位:
Epigenomic Mechanism of Parkinson's Disease
-
批准号:8738730
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Epigenomic Mechanism of Parkinson's Disease
-
批准号:8547489
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
-
批准号:9261605
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:10614554
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
-
批准号:8829930
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:8869054
-
项目类别:
-
资助金额:$9.17万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:10213144
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:9085404
-
项目类别:
-
资助金额:$9.26万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:10425313
-
项目类别:
-
资助金额:$15.68万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Training in Neurodegenerative Diseases
-
批准号:9302851
-
项目类别:
-
资助金额:$8.07万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
-
批准号:8689195
-
项目类别:
-
资助金额:$41.11万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
-
批准号:8607355
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2013
-
负责人:Xiongwei Zhu
-
依托单位:
LRRK2 and mitochondrial dysfunction
-
批准号:8130881
-
项目类别:
-
资助金额:$23.08万
-
财政年份:2010
-
负责人:Xiongwei Zhu
-
依托单位:
LRRK2 and mitochondrial dysfunction
-
批准号:8048530
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2010
-
负责人:Xiongwei Zhu
-
依托单位:
Mitochondrial Fission and Fusion in Alzheimer Disease
-
批准号:7800269
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2008
-
负责人:Xiongwei Zhu
-
依托单位:
Mitochondrial Fission and Fusion in Alzheimer Disease
-
批准号:8230562
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2008
-
负责人:Xiongwei Zhu
-
依托单位:
Mitochondrial Fission and Fusion in Alzheimer Disease
-
批准号:7439456
-
项目类别:
-
资助金额:$32.01万
-
财政年份:2008
-
负责人:Xiongwei Zhu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: